IP Library Granted Patent US 7,235,665
Granted Patent B2
US 7,235,665 · App. 10/829,803 · Granted Jun 26, 2007

Process for the production of piperidine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,235,665
App. No.
10/829,803
Granted
Jun 26, 2007
Kind
B2
Abstract

The present invention relates to processes for preparing certain piperidine derivatives, including fexofenadine (F), the active ingredient in the non-sedating antihistamine sold in the U.S. under the designation “Allegra®”. This invention also relates to novel synthetic intermediates useful in the processes of the present invention.

Claims (20)

1. A compound of formula (IX):

wherein alkyl is 1–6 carbon atoms.

2. The compound of claim 1 wherein the alkyl is methyl.

3. The compound of claim 1 wherein the alkyl is ethyl.

4. The process for preparing a piperidine derivative compound of formula (IX):

wherein alkyl is 1–6 carbon atoms comprising providing a compound of formula (VIII):

wherein alkyl is 1–6 carbon atoms, and converting the compound of formula (VIII) to the piperidine derivative compound of formula (IX) with a piperidine compound of formula (23):

5. The process according to claim 4 , wherein said providing comprises:

a) acylating a starting compound of formula (21):

wherein alkyl is 1–6 carbon atoms with a compound of formula (18)

under conditions effective to produce a mixture of regioisomers of formula (25):

wherein alkyl is 1–6 carbon atoms; and

b) recovering from the mixture of regioisomers the compound of formula (VIII):

wherein alkyl is 1–6 carbon atoms.

6. The process according to claim 5 wherein said recovering comprises crystallizing a regioisomeric salt of formula (VIIIa):

wherein alkyl is 1–6 carbon atoms and X + is a Lewis acid.

7. The process according to claim 6 wherein said recovering comprises crystallizing a regioisomeric salt of formula (VIIIa′):

wherein alkyl is 1–6 carbon atoms.

8. The process according to claim 5 wherein the alkyl is methyl.

9. The process according to claim 5 wherein the alkyl is ethyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2007
From: SCHROEDER, COLLIN; HUDDLESTON, RYAN; CHARLES, RICHARD
To: AVENTIS PHARMA DEUTSCHLAND GMBH
Reel/Frame 019269/0654 →
CHANGE OF NAME Recorded May 9, 2007
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 019270/0307 →
CHANGE OF NAME Recorded Nov 18, 2005
From: AVENTIS PHARMA DEUTSCHLAND GMBH
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 016793/0789 →